Interferon regulatory factor-1 as a positive regulator for high glucose-induced proliferation of vascular smooth muscle cells

Journal of Cellular Biochemistry

Volumn 113, Issue 8, 2012, Pages 2671-2678

  Sun, Yu ^a   Zhang, Xi ^a   Chen, Hai Yan ^b   Chi, Ya Li ^a   Xiong, Shao Hu ^a   Zhang, Chuan Sen ^a   Yang, Xiang Qun ^a   Guo, Jin Ping ^a   Lin, Hai Yan ^a   Dong, Lei ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Cell proliferation; Diabetic vascular diseases; Interferon regulatory factor 1; Vascular smooth muscle cells

Indexed keywords

GLUCOSE; INTERFERON REGULATORY FACTOR 1; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RAT; SMOOTH MUSCLE FIBER; STREPTOZOCIN DIABETES; THORACIC AORTA; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; GLUCOSE; IMMUNOHISTOCHEMISTRY; INTERFERON REGULATORY FACTOR-1; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84862532743     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24142     Document Type: Article

References (15)

1. Aronson D. 2008. Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol 45:1-16.
2. Dror N, Alter-Koltunoff M, Azriel A, Amariglio N, Jacob-Hirsch J, Zeligson S, Morgenstern A, Tamura T, Hauser H, Rechavi G, Ozato K, Levi BZ. 2007. Identification of IRF-8 and IRF-1 target genes in activated macrophages. Mol Immunol 44:338-346. (Pubitemid 44308354)
3. Eckert M, Meek SE, Ball KL. 2006. A novel repressor domain is required for maximal growth inhibition by the IRF-1 tumor suppressor. J Biol Chem 281:23092-23102.
4. Faries PL, Rohan DI, Takahara H, Wyers MC, Contreras MA, Quist WC, King GL, Logerfo FW. 2001. Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg 33:601-607. (Pubitemid 32215612)
5. Haller H, Drab M, Luft FC. 1996. The role of hyperglycemia and hyperinsulinemia in the pathogenesis of diabetic angiopathy. Clin Nephrol 46:246-255. (Pubitemid 26385559)
6. Hsueh WA, Jackson S, Law RE. 2001. Control of vascular cell proliferation and migration by PPAR-gamma: A new approach to the macrovascular complications of diabetes. Diabetes Care 24:392-397. (Pubitemid 32119143)
7. Kirchhoff S, Schaper F, Hauser H. 1993. Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes. Nucleic Acids Res 21:2881-2889. (Pubitemid 23220440)
8. Li Z, Wang ZG, Bian C, Chen XD, Li JW, Chen X, Han B, Hou GF, Chu J, Cui Q. 2009. Interferon regulatory factor-1 exerts inhibitory effect on neointimal formation after vascular injury. Chin Med Sci J 24:91-96.
9. Madi HA, Riches K, Warburton P, O'Regan DJ, Turner NA, Porter KE. 2009. Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients. Am J Physiol Cell Physiol 297:C1307-C1317.
10. Mikhail N, Fukuda N, Tremblay J, Hamet P. 1993. Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes. J Cardiovasc Pharmacol 22(Suppl. 6):S64-S74. (Pubitemid 23346739)
11. Orasanu G, Plutzky J. 2009. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 53:S35-S42.
12. Reusch JE, Wang CC. 2011. Cardiovascular disease in diabetes: Where does glucose fit in? J Clin Endocrinol Metab 96:2367-2376.
13. Romeo G, Fiorucci G, Chiantore MV, Percario ZA, Vannucchi S, Affabris E. 2002. IRF-1 as a negative regulator of cell proliferation. J Interferon Cytokine Res 22:39-47. (Pubitemid 34161281)
14. Srivastava AK. 2002. High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: A potential role in the pathogenesis of vascular dysfunction in diabetes (review). Int J Mol Med 9:85-89.
15. Vranes D, Cooper ME, Dilley RJ. 1999. Cellular mechanisms of diabetic vascular hypertrophy. Microvasc Res 57:8-18. (Pubitemid 29389918)